We found that overexpression of EBP50 inhibited EGF-induced breast cancer MDA-MB-231 cell proliferation, whereas knockdown of EBP50 enhanced EGF-induced breast cancer MCF-7 cell proliferation (Fig. 2). This evidence concerns the gene NHERF1 and breast cancer.